UNITED HEALTH PRODUCTS, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
UNITED HEALTH PRODUCTS, INC. (UEEC) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$40.75 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- UNITED HEALTH PRODUCTS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$64.22K.
- UNITED HEALTH PRODUCTS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$163.97K.
- UNITED HEALTH PRODUCTS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$14.54K, a 178.25% decline year-over-year.
- UNITED HEALTH PRODUCTS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $18.58K, a 66.53% increase year-over-year.
- UNITED HEALTH PRODUCTS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $82.04K.
- UNITED HEALTH PRODUCTS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$8.42K.
- UNITED HEALTH PRODUCTS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2021 was -$24.28K, a 182.43% decline from fiscal 2020.
- UNITED HEALTH PRODUCTS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2020 was $29.45K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$40.75K 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$64.22K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | -$103.63K POS AM · filed 2026-05-11 | |||
| 2025-09-30 | -$150.51K 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | -$168.66K 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | -$163.97K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $73.46K POS AM · filed 2026-05-11 | |||
| 2024-09-30 | -$51.64K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | -$76.67K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$14.54K 10-Q · filed 2025-05-05 | |||
| 2023-12-31 | $82.04K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | $60.66K 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $120.22K 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | $18.58K 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$8.42K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $74.90K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | -$15.38K 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | $11.16K 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | -$24.28K 10-K · filed 2023-03-28 | |||
| 2021-09-30 | $107.37K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $29.45K 10-K · filed 2022-04-01 |